Rxsight Inc (RXST) Stock Price, Quote & News

Company Profile

RxSight, Inc., a commercial-stage medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. The company's RxSight system includes RxSight Light Adjustable Lens (LAL), an intraocular lens made of photosensitive material that changes shape in response...

Industry: Medical Devices

Sector: Healthcare

Phone: 949 521 7830

Website: www.rxsight.com

Address:

100 Columbia, Aliso Viejo, United States

Iunited267 Jul. 16 at 5:00 PM

$RXST Great tech, useless stock

0 · Reply

PivotSnap19 Jul. 16 at 2:52 PM

$RXST⁩ ⁨WKSP buyers are lifting bids post‑Q2 beat 🚀 • Tape pushing from low $3.80s toward $4.00 • Key levels: $3.85 support / $4.00 resistance Volume surge could fuel next leg up 👀⁩

0 · Reply

Dunn94 Jul. 15 at 2:57 PM

$RXST

0 · Reply

BryGuy29 Jul. 15 at 2:18 PM

$RXST geez. When will the bleeding stop?

0 · Reply

Sam313 Jul. 14 at 1:37 AM

$RXST

0 · Reply

Omegacy2 Jul. 12 at 8:35 PM

i used to buy stocks that are cheap friday for monday bounce. $ZETA is one of them. i have order to shorted and misses order 15.99 and hod 15.86 etc... bc market are expensive. $ZETA friday i am in 13.9-14.01 for a bounce monday 14.5-15+. after that it depend of market condition. if zeta have an good articles that pump ai software zeta used for news. analysts pt 25. it pre er rally or not. @kenarcher i am in for a bounce and scalps many +5-10% $HELE $BYRN $CAPR $RXST since few days. msgs posted.

1 · Reply

Iunited267 Jul. 11 at 6:29 PM

$RXST I think this will settle 7.30-7.70 for now

0 · Reply

Sam313 Jul. 11 at 11:31 AM

$RXST

0 · Reply

Omegacy2 Jul. 10 at 11:45 PM

i have scalps yesterday 3x $RXST +0.3-1.3. in 6.3s and today i misses +0.8 order 7.51 and lod 7.65. today i scalp 3x $HELE +1-2.5 from in 21.9s 2x $BYRN +0.3-1 that is double the maximum profits by scalping instead of holding. @Phil_Leotardo69 a moron and a loser to lol at $SPY 510 my called msg below for +5-10% and +25% have come. Apr 21, 2025 11:49 AM $SPY 510 i pt 515-520+ bc each times spy drop 3-5% and it bounce +5-10%. since spy 505 called. 5x times i dip buy for a bounce 3-5x +5-25% nvda nbis rh and i re shorted vxx 74-76. i have scalps 5x +5-25% from 72-87.5

0 · Reply

daleloyd Jul. 10 at 11:26 PM

$RXST buying here is a no-brainer

0 · Reply

Robbins LLP is Investigating the Officers and Directors of RxSight, Inc. (RXST) to Determine if They Breached Fiduciary Duties Owed to Shareholders

Jul 11, 2025, 10:12 AM EDT - 5 days ago

Johnson Fistel Begins Investigation on Behalf of RxSight, Inc. (RXST) Shareholders

Jul 9, 2025, 1:33 PM EDT - 7 days ago

Crude Oil Moves Higher; RxSight Shares Plunge

Jul 9, 2025, 8:18 AM EDT - 7 days ago

Aehr Test Systems Posts Downbeat Sales, Joins RxSight, Vertical Aerospace And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session

AEHR EVTL

Jul 8, 2025, 4:05 PM EDT - 7 days ago

RxSight, Inc. Announces Preliminary Second Quarter 2025 Revenue and Revised 2025 Guidance

Jun 7, 2025, 9:32 AM EDT - 5 weeks ago

RxSight: Valuation Blowout Creates Opportunity

May 20, 2025, 4:10 PM EDT - 2 months ago

RxSight, Inc. to Participate in the Stifel 2025 Virtual Ophthalmology Forum

May 9, 2025, 7:16 AM EDT - 2 months ago

Top 3 Health Care Stocks That Are Preparing To Pump This Quarter

PRTA SRPT

May 7, 2025, 11:04 PM EDT - 2 months ago

RxSight, Inc. (RXST) Q1 2025 Earnings Call Transcript

Apr 30, 2025, 4:05 PM EDT - 2 months ago

RxSight, Inc. to Present at the Bank of America Healthcare Conference

Apr 3, 2025, 5:57 PM EDT - 3 months ago

RxSight: Navigating Market Headwinds Amid Intensifying Competition (Downgrade)

Apr 3, 2025, 3:54 PM EDT - 3 months ago

RxSight, Inc. (RXST) Q1 2025 Preliminary Results Conference Call (Transcript)

Apr 2, 2025, 8:00 PM EDT - 3 months ago

RxSight, Inc. Announces Preliminary First Quarter 2025 Revenue and Revised 2025 Guidance

Mar 25, 2025, 4:05 PM EDT - 4 months ago

RxSight, Inc. to Participate in the 24th Annual Needham Virtual Healthcare Conference

Feb 26, 2025, 6:35 AM EST - 5 months ago

RxSight, Inc. (RXST) Q4 2024 Earnings Call Transcript

Feb 25, 2025, 4:05 PM EST - 5 months ago

RxSight, Inc. Reports Fourth Quarter and Full-Year 2024 Financial Results, Reaffirms 2025 Guidance

Jan 12, 2025, 9:30 AM EST - 6 months ago

RxSight, Inc. Announces Preliminary Unaudited Fourth Quarter and Full-Year 2024 Financial and Operational Results and 2025 Guidance

Jan 2, 2025, 4:05 PM EST - 6 months ago

RxSight, Inc. to Present at the J.P. Morgan Healthcare Conference

Nov 29, 2024, 12:04 PM EST - 8 months ago

RxSight's Momentum In The Large Cataract Surgery Market Merits A Close Eye

Nov 9, 2024, 1:32 PM EST - 8 months ago

RxSight, Inc. (RXST) Q3 2024 Earnings Call Transcript

Oct 24, 2024, 4:05 PM EDT - 9 months ago

RxSight, Inc. to Report Third Quarter Financial Results on November 7, 2024

Aug 22, 2024, 4:05 PM EDT - 11 months ago

RxSight, Inc. to Participate in Upcoming Morgan Stanley and Wells Fargo Healthcare Conferences

Aug 13, 2024, 4:50 PM EDT - 1 year ago

Investing In The Future Of Cataract Surgery: The RxSight Advantage

Aug 5, 2024, 9:45 PM EDT - 1 year ago

RxSight, Inc. (RXST) Q2 2024 Earnings Call Transcript

Aug 5, 2024, 4:05 PM EDT - 1 year ago

RxSight, Inc. Reports Second Quarter 2024 Financial Results

Jul 22, 2024, 4:05 PM EDT - 1 year ago

RxSight, Inc. to Report Second Quarter Financial Results on August 5, 2024

Jun 5, 2024, 4:05 PM EDT - 1 year ago

RxSight, Inc. To Participate in the Truist Securities Medtech Conference

May 13, 2024, 4:05 PM EDT - 1 year ago

RxSight, Inc. Announces Closing of its Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares

May 8, 2024, 9:15 PM EDT - 1 year ago

RxSight, Inc. Announces Pricing of Public Offering of Common Stock

May 6, 2024, 10:06 PM EDT - 1 year ago

RxSight, Inc. (RXST) Q1 2024 Earnings Call Transcript

May 6, 2024, 4:05 PM EDT - 1 year ago

RxSight, Inc. Reports First Quarter 2024 Financial Results

Apr 22, 2024, 4:05 PM EDT - 1 year ago

RxSight, Inc. to Report First Quarter Financial Results on May 6, 2024

Apr 4, 2024, 4:05 PM EDT - 1 year ago

RxSight Announces Commercial Launch of its Newest Light Adjustable Lens™, the LAL+™, and Features Multiple Doctor Presentations at the Upcoming ASCRS Annual Meeting

Mar 27, 2024, 4:05 PM EDT - 1 year ago

RxSight, Inc. to Participate in the 23rd Annual Needham Virtual Healthcare Conference

Feb 29, 2024, 7:05 PM EST - 1 year ago

RxSight, Inc. to Participate in the 34th Annual Oppenheimer Healthcare Conference

Feb 28, 2024, 11:44 PM EST - 1 year ago

RxSight, Inc. (RXST) Q4 2023 Earnings Call Transcript

Feb 28, 2024, 4:05 PM EST - 1 year ago

RxSight, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results

Feb 14, 2024, 4:05 PM EST - 1 year ago

RxSight, Inc. to Report Fourth Quarter and Full Year 2023 Financial Results on February 28, 2024

Jan 7, 2024, 10:00 AM EST - 1 year ago

RxSight, Inc. Announces Preliminary Unaudited Fourth Quarter and Full-Year 2023 Financial and Operational Results and 2024 Guidance

Nov 12, 2023, 4:19 AM EST - 1 year ago

RxSight, Inc. (RXST) Q3 2023 Earnings Call Transcript

Nov 2, 2023, 9:00 AM EDT - 1 year ago

RxSight, Inc. Educational and Product Announcements for AAO 2023

Oct 27, 2023, 11:12 AM EDT - 1 year ago

RxSight: Losing Altitude Despite 'Best Of Breed' Platform

Oct 23, 2023, 11:52 AM EDT - 1 year ago

Trading The Top-Performing AI Companies From The Small Cap Universe

INOD IONQ PSCT RGTI

Aug 23, 2023, 4:05 PM EDT - 2 years ago

RxSight, Inc. to Present at the Wells Fargo Healthcare Conference

Aug 7, 2023, 8:56 PM EDT - 2 years ago

RxSight, Inc. (RXST) Q2 2023 Earnings Call Transcript

Aug 7, 2023, 4:05 PM EDT - 2 years ago

RxSight, Inc. Reports Second Quarter 2023 Financial Results

Jul 25, 2023, 4:05 PM EDT - 2 years ago

RxSight, Inc. to Report Second Quarter Financial Results on August 7, 2023

May 13, 2023, 7:14 PM EDT - 2 years ago

RxSight, Inc. (RXST) Q1 2023 Earnings Call Transcript

Iunited267 Jul. 16 at 5:00 PM

$RXST Great tech, useless stock

0 · Reply

PivotSnap19 Jul. 16 at 2:52 PM

$RXST⁩ ⁨WKSP buyers are lifting bids post‑Q2 beat 🚀 • Tape pushing from low $3.80s toward $4.00 • Key levels: $3.85 support / $4.00 resistance Volume surge could fuel next leg up 👀⁩

0 · Reply

Dunn94 Jul. 15 at 2:57 PM

$RXST

0 · Reply

BryGuy29 Jul. 15 at 2:18 PM

$RXST geez. When will the bleeding stop?

0 · Reply

Sam313 Jul. 14 at 1:37 AM

$RXST

0 · Reply

Omegacy2 Jul. 12 at 8:35 PM

1 · Reply

Iunited267 Jul. 11 at 6:29 PM

$RXST I think this will settle 7.30-7.70 for now

0 · Reply

Sam313 Jul. 11 at 11:31 AM

$RXST

0 · Reply

Omegacy2 Jul. 10 at 11:45 PM

0 · Reply

daleloyd Jul. 10 at 11:26 PM

$RXST buying here is a no-brainer

0 · Reply

Sam313 Jul. 10 at 8:47 PM

$RXST 12

0 · Reply

Sam313 Jul. 10 at 6:24 PM

$RXST 12

0 · Reply

daleloyd Jul. 10 at 4:35 PM

$RXST this is an amazing opportunity at this price 💰

0 · Reply

Gmblr777 Jul. 10 at 4:03 PM

$RXST Please dont dump 🥲🥲

0 · Reply

onemillion2012 Jul. 10 at 2:34 PM

$RXST sold. 20 percent gain on one day beautiful. Do i buy $ASMB or $VNDA

4 · Reply

Omegacy2 Jul. 10 at 2:31 PM

$RXST 8.4s as i pt 8-9 for today. another winner. i have scalp many +0.3-1.3 and misses +0.8 more. i misses order 7.51 lod 7.65.

1 · Reply

Sterling7272 Jul. 10 at 2:26 PM

$RXST LFG!!! Back to 10😂😂😂

0 · Reply

StackOrigin Jul. 10 at 2:23 PM

$RXST

0 · Reply

RocketThief Jul. 10 at 2:05 PM

$RXST classic reactive analysts - adjust after the big news (actual value would have been predicting a second guidance chop). They’ll fail to predict the turnaround before it happens and then adjust upward in reaction once again

0 · Reply

Omegacy2 Jul. 10 at 1:58 PM

$RXST 8.1s i misses. order 7.51 and lod 7.65. glta as i pt 8-9 after scalp many +0.3-1.3.

0 · Reply

Richpoembai Jul. 10 at 1:33 PM

$RXST cashed out 🤙

0 · Reply

SebastianCrenshaw Jul. 10 at 12:37 PM

$RXST entre prices ?

0 · Reply

Market Cap	314.53M
Revenue (ttm)	139.93M
Net Income (ttm)	-27.46M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-19.62%
Debt to Equity Ratio	0.00

Volume	465,124
Avg Vol	1,346,820
Day's Range	N/A - N/A
Shares Out	40.64M
Stochastic %K	15%
Beta	1.21
Analysts	Hold
Price Target	$13.44